Karuna Therapeutics Inc reports results for the quarter ended in September - Earnings Summary

Karuna Therapeutics

03/11/2022 11:37

* Karuna Therapeutics Inc  KRTX.OQ  reported a quarterly
adjusted
loss of $2.38​​ per share for the quarter ended in September.
The mean expectation of eighteen analysts for the quarter was
for a loss of $2.13 per share.
    * Revenue was $81.00 thousand​; analysts expected zero. 
    * Karuna Therapeutics Inc's reported EPS for the quarter was
a
loss of $2.38​.
    * The mean earnings estimate of analysts had fallen by
about 5.9%
in the last three months.​ 
    * In the last 30 days there have been no negative revisions
of
earnings estimates 
    * Karuna Therapeutics Inc shares had fallen by 3.2% this
quarter and gained 66.2% so far this year.
    * The company reported a quarterly loss of $76.96 million.
    * Wall Street's median 12-month price target for Karuna
Therapeutics Inc is $286.00 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 19 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 

This summary was machine generated from Refinitiv data November
3 at 11:37 a.m.  ​All figures in US dollars unless otherwise
stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Sep. 30 2022      -2.13          -2.38          Missed
 Jun. 30 2022      -2.09          -2.17          Missed
 Mar. 31 2022      -2.11          -1.95          Beat
 Dec. 31 2021      -1.73          -0.94          Beat